Suppr超能文献

一种扩展的 RT-PCR 熔解温度编码检测方法,可快速鉴定所有已知的 SARS-CoV-2 变体和关注的亚变体。

An expanded RT-PCR melting temperature coding assay to rapidly identify all known SARS-CoV-2 variants and sub-variants of concern.

机构信息

Rutgers New Jersey Medical School, Public Health Research Institute, Newark, NJ, USA.

Institute of Genomic Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.

出版信息

Sci Rep. 2023 Dec 11;13(1):21927. doi: 10.1038/s41598-023-48647-8.

Abstract

The continued emergence of vaccine-resistant SARS-CoV-2 variants of concern (VOC) requires specific identification of each VOC as it arises. Here, we report an expanded version of our previously described sloppy molecular beacon (SMB) melting temperature (Tm) signature-based assay for VOCs, now modified to include detection of Delta (B.1.617.2) and Omicron (B.1.1.529) sub-variants. The SMB-VOC assay targets the signature codons 501, 484 and 452 in the SARS-CoV-2 spike protein which we show can specifically detect and differentiate all known VOCs including the Omicron subvariants (BA.1, BA.2, BA.2.12.1, BA.4/BA.5). The limit of detection (LOD) of the assay was 20, 22 and 36 genomic equivalents (GE) per reaction with the Delta, Omicron BA.1 and BA.2 respectively. Clinical validation of the 3-codon assay in the LC480 instrument showed the assay detected 94% (81/86) of the specimens as WT or VOCs and 6% (5/86) of the tests producing indeterminate results compared to sequencing. Sanger sequencing also failed for four samples. None of the specimens were incorrectly identified as WT or as a different VOC by our assay. Thus, excluding specimens with indeterminant results, the assay was 100% sensitive and 100% specific compared to Sanger sequencing for variant identification. This new assay concept can be easily expanded to add newer variants and can serve as a robust diagnostic tool for selecting appropriate monoclonal antibody therapy and rapid VOC surveillance.

摘要

持续出现的具有疫苗抗性的 SARS-CoV-2 变体需要在每个变体出现时进行特定的识别。在这里,我们报告了一个扩展版本的之前描述的基于分子信标的熔解温度(Tm)的 SARS-CoV-2 变体的特征检测方法,现在修改为包括对 Delta(B.1.617.2)和奥密克戎(B.1.1.529)亚变体的检测。SMB-VOC 检测方法针对 SARS-CoV-2 刺突蛋白中的特征密码子 501、484 和 452,我们证明该方法可以特异性检测和区分所有已知的变体,包括奥密克戎亚变体(BA.1、BA.2、BA.2.12.1、BA.4/BA.5)。该检测方法的检测限(LOD)分别为每个反应 20、22 和 36 个基因组当量(GE),分别对应于 Delta、奥密克戎 BA.1 和 BA.2。在 LC480 仪器中对 3 个密码子检测方法的临床验证表明,与测序相比,该检测方法检测到 94%(81/86)的样本为 WT 或 VOC,6%(5/86)的检测结果为不确定。Sanger 测序也未能对 4 个样本进行测序。我们的检测方法没有将任何样本错误地识别为 WT 或其他变体。因此,不包括检测结果不确定的样本,与 Sanger 测序相比,该检测方法在变体识别方面的灵敏度为 100%,特异性为 100%。这种新的检测方法概念可以很容易地扩展到添加新的变体,并可以作为一种强大的诊断工具,用于选择适当的单克隆抗体治疗和快速的 VOC 监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4d4/10713575/b7f1e1b31bd8/41598_2023_48647_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验